Urinary adiponectin and albuminuria in non-diabetic hypertensive patients: An analysis of the ESPECIAL trial

Seung Seok Han, Eunjin Bae, Shin Young Ahn, Sejoong Kim, Jung Hwan Park, Sung Joon Shin, Sang Ho Lee, Bum Soon Choi, Ho Jun Chin, Chun Soo Lim, Suhnggwon Kim, Dong Ki Kim

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Although adiponectin levels have been reported to be correlated with albuminuria, this issue remains unresolved in non-diabetic hypertensive subjects, particularly when urinary adiponectin is considered. Methods: Urinary adiponectin levels were examined using an enzyme-linked immunosorbent assay in 229 participants. who used olmesartan as a hypertensive agent. Their albuminuria levels were measured for 16 weeks after randomization and initiation of conventional or intensive diet education. Linear or logistic regression models were applied, as appropriate, to explore the relationship with albuminuria itself or its response after the intervention. Results: Urinary adiponectin levels were positively related to baseline albuminuria level (r = 0.529). After adjusting for several covariates, the adiponectin level was associated with the albuminuria level (β = 0.446). Among the 159 subjects with baseline macroalbuminuria, the risk of consistent macroalbuminuria (> 300 mg/day) at 16 weeks was higher in the 3rd tertile of adiponectin than in the 1st tertile (odds ratio = 6.9), despite diet education. In contrast, among all subjects, the frequency of the normoalbuminuria achievement (< 30 mg/day) at 16 weeks was higher in the 1st tertile than in the 3rd tertile (odds ratio = 13.0). Conclusions: Urinary adiponectin may be a useful biomarker for albuminuria or its response after treatment in non-diabetic hypertensive patients.

Original languageEnglish
Article number123
JournalBMC Nephrology
Volume16
Issue number1
DOIs
Publication statusPublished - 2015 Aug 1
Externally publishedYes

Fingerprint

Albuminuria
Adiponectin
Logistic Models
Odds Ratio
Diet
Education
Random Allocation
Linear Models
Biomarkers
Enzyme-Linked Immunosorbent Assay

Keywords

  • Adiponectin
  • Albuminuria
  • Biomarker
  • Kidney
  • Urine

ASJC Scopus subject areas

  • Nephrology

Cite this

Urinary adiponectin and albuminuria in non-diabetic hypertensive patients : An analysis of the ESPECIAL trial. / Han, Seung Seok; Bae, Eunjin; Ahn, Shin Young; Kim, Sejoong; Park, Jung Hwan; Shin, Sung Joon; Lee, Sang Ho; Choi, Bum Soon; Chin, Ho Jun; Lim, Chun Soo; Kim, Suhnggwon; Kim, Dong Ki.

In: BMC Nephrology, Vol. 16, No. 1, 123, 01.08.2015.

Research output: Contribution to journalArticle

Han, SS, Bae, E, Ahn, SY, Kim, S, Park, JH, Shin, SJ, Lee, SH, Choi, BS, Chin, HJ, Lim, CS, Kim, S & Kim, DK 2015, 'Urinary adiponectin and albuminuria in non-diabetic hypertensive patients: An analysis of the ESPECIAL trial', BMC Nephrology, vol. 16, no. 1, 123. https://doi.org/10.1186/s12882-015-0124-3
Han, Seung Seok ; Bae, Eunjin ; Ahn, Shin Young ; Kim, Sejoong ; Park, Jung Hwan ; Shin, Sung Joon ; Lee, Sang Ho ; Choi, Bum Soon ; Chin, Ho Jun ; Lim, Chun Soo ; Kim, Suhnggwon ; Kim, Dong Ki. / Urinary adiponectin and albuminuria in non-diabetic hypertensive patients : An analysis of the ESPECIAL trial. In: BMC Nephrology. 2015 ; Vol. 16, No. 1.
@article{69d313e4153347e19e8e47eb1c1d8b70,
title = "Urinary adiponectin and albuminuria in non-diabetic hypertensive patients: An analysis of the ESPECIAL trial",
abstract = "Background: Although adiponectin levels have been reported to be correlated with albuminuria, this issue remains unresolved in non-diabetic hypertensive subjects, particularly when urinary adiponectin is considered. Methods: Urinary adiponectin levels were examined using an enzyme-linked immunosorbent assay in 229 participants. who used olmesartan as a hypertensive agent. Their albuminuria levels were measured for 16 weeks after randomization and initiation of conventional or intensive diet education. Linear or logistic regression models were applied, as appropriate, to explore the relationship with albuminuria itself or its response after the intervention. Results: Urinary adiponectin levels were positively related to baseline albuminuria level (r = 0.529). After adjusting for several covariates, the adiponectin level was associated with the albuminuria level (β = 0.446). Among the 159 subjects with baseline macroalbuminuria, the risk of consistent macroalbuminuria (> 300 mg/day) at 16 weeks was higher in the 3rd tertile of adiponectin than in the 1st tertile (odds ratio = 6.9), despite diet education. In contrast, among all subjects, the frequency of the normoalbuminuria achievement (< 30 mg/day) at 16 weeks was higher in the 1st tertile than in the 3rd tertile (odds ratio = 13.0). Conclusions: Urinary adiponectin may be a useful biomarker for albuminuria or its response after treatment in non-diabetic hypertensive patients.",
keywords = "Adiponectin, Albuminuria, Biomarker, Kidney, Urine",
author = "Han, {Seung Seok} and Eunjin Bae and Ahn, {Shin Young} and Sejoong Kim and Park, {Jung Hwan} and Shin, {Sung Joon} and Lee, {Sang Ho} and Choi, {Bum Soon} and Chin, {Ho Jun} and Lim, {Chun Soo} and Suhnggwon Kim and Kim, {Dong Ki}",
year = "2015",
month = "8",
day = "1",
doi = "10.1186/s12882-015-0124-3",
language = "English",
volume = "16",
journal = "BMC Nephrology",
issn = "1471-2369",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Urinary adiponectin and albuminuria in non-diabetic hypertensive patients

T2 - An analysis of the ESPECIAL trial

AU - Han, Seung Seok

AU - Bae, Eunjin

AU - Ahn, Shin Young

AU - Kim, Sejoong

AU - Park, Jung Hwan

AU - Shin, Sung Joon

AU - Lee, Sang Ho

AU - Choi, Bum Soon

AU - Chin, Ho Jun

AU - Lim, Chun Soo

AU - Kim, Suhnggwon

AU - Kim, Dong Ki

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Background: Although adiponectin levels have been reported to be correlated with albuminuria, this issue remains unresolved in non-diabetic hypertensive subjects, particularly when urinary adiponectin is considered. Methods: Urinary adiponectin levels were examined using an enzyme-linked immunosorbent assay in 229 participants. who used olmesartan as a hypertensive agent. Their albuminuria levels were measured for 16 weeks after randomization and initiation of conventional or intensive diet education. Linear or logistic regression models were applied, as appropriate, to explore the relationship with albuminuria itself or its response after the intervention. Results: Urinary adiponectin levels were positively related to baseline albuminuria level (r = 0.529). After adjusting for several covariates, the adiponectin level was associated with the albuminuria level (β = 0.446). Among the 159 subjects with baseline macroalbuminuria, the risk of consistent macroalbuminuria (> 300 mg/day) at 16 weeks was higher in the 3rd tertile of adiponectin than in the 1st tertile (odds ratio = 6.9), despite diet education. In contrast, among all subjects, the frequency of the normoalbuminuria achievement (< 30 mg/day) at 16 weeks was higher in the 1st tertile than in the 3rd tertile (odds ratio = 13.0). Conclusions: Urinary adiponectin may be a useful biomarker for albuminuria or its response after treatment in non-diabetic hypertensive patients.

AB - Background: Although adiponectin levels have been reported to be correlated with albuminuria, this issue remains unresolved in non-diabetic hypertensive subjects, particularly when urinary adiponectin is considered. Methods: Urinary adiponectin levels were examined using an enzyme-linked immunosorbent assay in 229 participants. who used olmesartan as a hypertensive agent. Their albuminuria levels were measured for 16 weeks after randomization and initiation of conventional or intensive diet education. Linear or logistic regression models were applied, as appropriate, to explore the relationship with albuminuria itself or its response after the intervention. Results: Urinary adiponectin levels were positively related to baseline albuminuria level (r = 0.529). After adjusting for several covariates, the adiponectin level was associated with the albuminuria level (β = 0.446). Among the 159 subjects with baseline macroalbuminuria, the risk of consistent macroalbuminuria (> 300 mg/day) at 16 weeks was higher in the 3rd tertile of adiponectin than in the 1st tertile (odds ratio = 6.9), despite diet education. In contrast, among all subjects, the frequency of the normoalbuminuria achievement (< 30 mg/day) at 16 weeks was higher in the 1st tertile than in the 3rd tertile (odds ratio = 13.0). Conclusions: Urinary adiponectin may be a useful biomarker for albuminuria or its response after treatment in non-diabetic hypertensive patients.

KW - Adiponectin

KW - Albuminuria

KW - Biomarker

KW - Kidney

KW - Urine

UR - http://www.scopus.com/inward/record.url?scp=84938565809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938565809&partnerID=8YFLogxK

U2 - 10.1186/s12882-015-0124-3

DO - 10.1186/s12882-015-0124-3

M3 - Article

C2 - 26232133

AN - SCOPUS:84938565809

VL - 16

JO - BMC Nephrology

JF - BMC Nephrology

SN - 1471-2369

IS - 1

M1 - 123

ER -